Ana Lucrecia Woodward

Array ( [id] => 6918752 [patent_doc_number] => 20050096313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Piperidine derivatives and their use as antagonists of tachykinins' [patent_app_type] => utility [patent_app_number] => 10/502261 [patent_app_country] => US [patent_app_date] => 2003-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17354 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096313.pdf [firstpage_image] =>[orig_patent_app_number] => 10502261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991459 [patent_doc_number] => 20050090496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Sulphonyl compounds with 5-ht6 receptor affinity' [patent_app_type] => utility [patent_app_number] => 10/503682 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3207 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090496.pdf [firstpage_image] =>[orig_patent_app_number] => 10503682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847498 [patent_doc_number] => 20030166665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => '4-,5-,6-And 7-indole derivatives useful for the treatment of CNS disorders' [patent_app_type] => new [patent_app_number] => 10/359052 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5789 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166665.pdf [firstpage_image] =>[orig_patent_app_number] => 10359052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835245 [patent_doc_number] => 20030162791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Phenylpiperazines' [patent_app_type] => new [patent_app_number] => 10/343232 [patent_app_country] => US [patent_app_date] => 2003-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1652 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162791.pdf [firstpage_image] =>[orig_patent_app_number] => 10343232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 928569 [patent_doc_number] => 07314879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Melanocortin receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/500476 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31150 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314879.pdf [firstpage_image] =>[orig_patent_app_number] => 10500476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852302 [patent_doc_number] => 20030144505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Novel compounds' [patent_app_type] => new [patent_app_number] => 10/345499 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3253 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144505.pdf [firstpage_image] =>[orig_patent_app_number] => 10345499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766357 [patent_doc_number] => 20030100757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => '2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor' [patent_app_type] => new [patent_app_number] => 10/340699 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9255 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100757.pdf [firstpage_image] =>[orig_patent_app_number] => 10340699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359772 [patent_doc_number] => 07485651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Compounds with activity on muscarinic receptors' [patent_app_type] => utility [patent_app_number] => 10/338937 [patent_app_country] => US [patent_app_date] => 2003-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14052 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485651.pdf [firstpage_image] =>[orig_patent_app_number] => 10338937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281332 [patent_doc_number] => 20040063709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => '3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/335789 [patent_app_country] => US [patent_app_date] => 2003-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21673 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063709.pdf [firstpage_image] =>[orig_patent_app_number] => 10335789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073805 [patent_doc_number] => 06838470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Arylpiperidinopropanol and arylpiprazinopropanol derivatives and pharmaceuticals containing the same' [patent_app_type] => utility [patent_app_number] => 10/331508 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21072 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838470.pdf [firstpage_image] =>[orig_patent_app_number] => 10331508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684206 [patent_doc_number] => 20030120070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Serotonin 5-HT1A and dopamin D2 receptor ligands' [patent_app_type] => new [patent_app_number] => 10/334481 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9804 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20030120070.pdf [firstpage_image] =>[orig_patent_app_number] => 10334481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740831 [patent_doc_number] => 20030158200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Pyridazinyl phenyl hydrazones useful against congestive heart failure' [patent_app_type] => new [patent_app_number] => 10/221348 [patent_app_country] => US [patent_app_date] => 2002-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9762 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158200.pdf [firstpage_image] =>[orig_patent_app_number] => 10221348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740834 [patent_doc_number] => 20030158203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Triazolo-pyridazine derivatives as ligands for GABA receptors' [patent_app_type] => new [patent_app_number] => 10/324968 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7693 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158203.pdf [firstpage_image] =>[orig_patent_app_number] => 10324968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814968 [patent_doc_number] => 20060084657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Piperazine derivative' [patent_app_type] => utility [patent_app_number] => 10/499011 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15327 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084657.pdf [firstpage_image] =>[orig_patent_app_number] => 10499011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805428 [patent_doc_number] => 20030232822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Indole derivatives useful for the treatment of CNS disorders' [patent_app_type] => new [patent_app_number] => 10/327670 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9086 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232822.pdf [firstpage_image] =>[orig_patent_app_number] => 10327670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330775 [patent_doc_number] => 20040254374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases' [patent_app_type] => new [patent_app_number] => 10/496019 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15366 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254374.pdf [firstpage_image] =>[orig_patent_app_number] => 10496019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651793 [patent_doc_number] => 20030105101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Prostaglandin endoperoxide H synthase biosynthesis inhibitors' [patent_app_type] => new [patent_app_number] => 10/313433 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17829 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105101.pdf [firstpage_image] =>[orig_patent_app_number] => 10313433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122921 [patent_doc_number] => 20050014750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Isochroman compounds for treatment of cns disorders' [patent_app_type] => utility [patent_app_number] => 10/496535 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24141 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014750.pdf [firstpage_image] =>[orig_patent_app_number] => 10496535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1062994 [patent_doc_number] => 06849632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-01 [patent_title] => 'Heteroaryl alkyl piperazine derivatives' [patent_app_type] => utility [patent_app_number] => 10/313818 [patent_app_country] => US [patent_app_date] => 2002-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17436 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 634 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849632.pdf [firstpage_image] =>[orig_patent_app_number] => 10313818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856774 [patent_doc_number] => 20030130275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Sulfonamide compounds with pharmaceutical activity' [patent_app_type] => new [patent_app_number] => 10/305450 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3274 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130275.pdf [firstpage_image] =>[orig_patent_app_number] => 10305450 [rel_patent_id] =>[rel_patent_doc_number] =>)